化干扰素Alfa- 2b空气注入的探索性药理学研究
Hongran Chu1, Hanzhou Wu1, Fenfang Zou2
1Biosteed Gene Expression Tech. Co., Ltd, Xiamen, China.
与标准干扰素α- 2b (IFNα- 2b) 相比,空气化基干扰素α- 2b (PEG IFNα- 2b) 的肺部药物暴露得到改善. 这表明PEG IFNα-2b可能会提供治疗效益,例如更少的剂量.
科学领域:
- 药理学
- 呼吸系统医学
- 药物输送系统
背景情况:
- 干扰素α- 2b (IFNα- 2b) 用于治疗各种疾病.
- 化IFNα-2b (PEG IFNα-2b) 的目的是改善其药物动力学特征.
- 直接输送到呼吸道是一种潜在的注射途径.
研究的目的:
- 为了比较PEG IFNα-2b与标准IFNα-2b的药理动力学和组织分布.
- 评估药物暴露和在下呼吸道中的保留.
- 为未来的药学动力学研究提供基础.
主要方法:
- 五十六只斯普拉格·道利大鼠接受了PEG IFNα-2b或IFNα-2b的单次喷雾剂量.
- 药物动力学参数 (Cmax,Tmax,AUC) 已经进行了评估.
- 血液和组织样本 (肺,气管,支气管) 在设定的时间间隔内进行分析.
主要成果:
- 与IFNα-2b相比,PEGIFNα-2b的肺部AUC和MRT显著更高.
- 药物保留在肺部,气管和支气管中显著增加了PEG IFNα-2b.
- 两种配方的全身暴露是最小的.
结论:
- 气溶性PEG IFNα-2b可增强药物暴露和在下呼吸道中的保留.
- 这种局部传递可能提供治疗优势,可能减少剂量频率.
- 需要进一步的研究来探索空气中PEG IFNα-2b的临床疗效和药理动力学.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Atomic Emission Spectroscopy: Interference
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Chronic Obstructive Pulmonary Disease II: Emphysema
